Ann Intern Med. 2000 Jun 20;132(12):959-63. Unique Identifier : AIDSLINE
BACKGROUND: Infection with hepatitis G virus (HGV), also known as GB
virus C, is prevalent but is not known to be associated with any chronic
disease. Infection with HGV may affect the risk for AIDS in HIV-infected
persons. OBJECTIVE: To compare AIDS-free survival in patients with and
those without HGV infection during 16 years of follow-up after HIV
seroconversion. DESIGN: Subanalysis of a prospective cohort study.
SETTING: Comprehensive hemophilia treatment centers in the United States
and Europe. PATIENTS: 131 patients with hemophilia who became
HIV-positive between 1978 and 1985. MEASUREMENTS: Age, CCR5 genotype,
HIV and HCV viral loads, CD4+ and CD8+ lymphocyte counts, and 12-year
AIDS-free survival by HGV positivity (viremia [RNA] or anti-E2
antibodies). RESULTS: Compared with HGV-negative patients, the 60
HGV-positive patients (46%), including 22 who were positive for HGV RNA,
had higher CD4+ lymphocyte counts (difference, 211 cells/mm3 [95% Cl, 88
to 333 cells/mm3]) and 12-year AIDS-free survival rates (68% compared
with 40%; rate difference, 1.9 per 100 person-years [Cl, -0.3 to 4.2 per
100 person-years]), despite similar ages and HIV viral loads. In
multivariate proportional hazards models, risk for AIDS was 40% lower
for HGV-positive patients independent of age, HIV and HCV viral loads,
CD4+ and CD8+ lymphocyte counts, and CCR5 genotype. CONCLUSIONS:
Patients with past or current HGV infection have higher CD4+ lymphocyte
counts and better AIDS-free survival rates. The mechanism of this
association is unknown.
JOURNAL ARTICLE MULTICENTER STUDY Acquired Immunodeficiency
Syndrome/ETIOLOGY CD4-CD8 Ratio Disease Progression Europe Follow-Up
Studies Gene Deletion Genotype Hemophilia A/*COMPLICATIONS Hepatitis
Agents, GB Hepatitis, Viral, Human/*COMPLICATIONS Human HIV
Infections/*COMPLICATIONS Male Proportional Hazards Models
Prospective Studies Receptors, CCR5/GENETICS Risk Factors Support,
U.S. Gov't, P.H.S. Survival Rate United States Viral Load
www.aegis.org